Cargando…
AMP-activated protein kinase promotes breast cancer stemness and drug resistance
Breast cancer stem cells (BCSCs) are a major cause of therapy resistance and tumour progression. Currently, their regulation is not entirely understood. Previous work from our laboratory demonstrated a context-specific pro-tumorigenic role for AMP-activated protein kinase (AMPK) under anchorage-depr...
Autores principales: | Andugulapati, Sai Balaji, Sundararaman, Ananthalakshmy, Lahiry, Mohini, Rangarajan, Annapoorni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150117/ https://www.ncbi.nlm.nih.gov/pubmed/35195687 http://dx.doi.org/10.1242/dmm.049203 |
Ejemplares similares
-
Calcium-Oxidant Signaling Network Regulates AMP-activated Protein Kinase (AMPK) Activation upon Matrix Deprivation
por: Sundararaman, Ananthalakshmy, et al.
Publicado: (2016) -
AMP-activated protein kinase promotes epithelial-mesenchymal transition in cancer cells through Twist1 upregulation
por: Saxena, Meera, et al.
Publicado: (2018) -
Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance
por: Balaji, Sai A., et al.
Publicado: (2016) -
A functional antagonism between RhoJ and Cdc42 regulates fibronectin remodelling during angiogenesis
por: Sundararaman, Ananthalakshmy, et al.
Publicado: (2020) -
Different Phases of Breast Cancer Cells: Raman Study of Immortalized, Transformed, and Invasive Cells
por: Chaturvedi, Deepika, et al.
Publicado: (2016)